Comparison of Lineblot and Immunoprecipitation Methods in the Detection of Myositis-Specific and Myositis-Associated Antibodies in Patients with Idiopathic Inflammatory Myopathies: Consistency with Clinical Diagnoses

被引:1
|
作者
Angeli, Fabrizio [1 ,2 ]
Pedretti, Eleonora [1 ,2 ]
Garrafa, Emirena [3 ]
Fredi, Micaela [1 ,2 ]
Ceribelli, Angela [4 ,5 ]
Franceschini, Franco [1 ,2 ]
Cavazzana, Ilaria [1 ]
机构
[1] ERN ReCONNET Ctr, Rheumatol & Clin Immunol Unit, ASST Spedali Civili, Piazzale Spedali Civili,1, I-25124 Brescia, Italy
[2] Univ Brescia, Clin & Expt Sci Dept, Piazzale Spedali Civili 1, I-25124 Brescia, Italy
[3] Univ Brescia, Cent Lab Unit, ASST Spedali Civili Mol & Transit Med, Piazzale Spedali Civili 1, I-25124 Brescia, Italy
[4] Human Res Hosp, Rheumatol & Clin Immunol IRCCS, via Manzoni 56, I-20089 Rozzano, Milano, Italy
[5] Human Univ, Dept Biomed Sci, I-20072 Pieve Emanuele, Milano, Italy
关键词
idiopathic inflammatory myopathies; dermatomyositis; polymyositis; immunoprecipitation; lineblot assay; autoantibodies; CLASSIFICATION CRITERIA; RHEUMATOLOGY/EUROPEAN LEAGUE; AMERICAN-COLLEGE; DISEASE-ACTIVITY; LUNG-DISEASE; AUTOANTIBODIES; DERMATOMYOSITIS;
D O I
10.3390/diagnostics14192192
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: the reference method for detection of myositis-specific and myositis-associated antibodies (MSAs and MAAs) is considered immunoprecipitation (IP), but it is routinely replaced by semi-automated methods, like lineblot (LB). Few data are available on the consistency with clinical diagnoses; thus, we aim at analysing these aspects. Methods: sixty-nine patients with idiopathic inflammatory myopathies (IIM) were studied via LB (Myositis Antigens Profile 3 EUROLINE, Euroimmun) and IP (RNA and protein antigens). The degree of concordance between methods was calculated using Cohen's coefficient. Results: a substantial concordance was found for anti-Ku and anti-PM/Scl and a moderate concordance was found for anti-Jo1 and anti-Mi-2, while a fair concordance was found for anti-EJ, anti-SRP, and anti-Ro52 antibodies. The concordance could not be calculated for anti-OJ, anti-PL-7, anti-PL-12, anti-NXP2, anti-TIF1 gamma, and anti-MDA5, because they were only detected with one method. Multiple MSAs were found only with LB in 2/69 sera. Anti-MDA5, TIF1 gamma, NXP2 (detected via IP), and anti-Jo1 in anti-synthetase syndrome (both LB and IP) had the best concordance with clinical diagnosis. Conclusions: LB and IP show substantial concordance for PM/Scl and Ku, and moderate concordance for Jo1 and Mi-2, with a good concordance with clinical diagnoses. IP shows a high performance for DM-associated MSAs. LB seems to be more sensitive in detecting anti-Ro52 antibodies, but it identified multiple MSAs, unlike IP.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy
    Minoru Satoh
    Shin Tanaka
    Angela Ceribelli
    S. John Calise
    Edward K. L. Chan
    Clinical Reviews in Allergy & Immunology, 2017, 52 : 1 - 19
  • [22] Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology
    Gomez, Graciela N.
    Perez, Nicolas
    Braillard Poccard, Andrea
    Gomez, Ramiro A.
    Costi, Ana C.
    Garcia, Mercedes A.
    Viola, Malena
    Benitez, Alejandro
    Aciar, Mariana M.
    Crespo Espindola, Maria
    Yucra, Demelza
    Cosatti, Micaela A.
    Pisoni, Cecilia
    Capelusnik, Dafne
    Lojo, Maria N.
    Barrios, Belen I.
    Rivero, Mariano
    Kisluk, Boris
    Granel, Amelia
    CLINICAL RHEUMATOLOGY, 2021, 40 (11) : 4473 - 4483
  • [23] Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology
    Graciela N. Gómez
    Nicolás Pérez
    Andrea Braillard Poccard
    Ramiro A. Gómez
    Ana C. Costi
    Mercedes A. García
    Malena Viola
    Alejandro Benitez
    Mariana M. Aciar
    María Crespo Espíndola
    Demelza Yucra
    Micaela A. Cosatti
    Cecilia Pisoni
    Dafne Capelusnik
    María N. Lojo
    Belen I. Barrios
    Mariano Rivero
    Boris Kisluk
    Amelia Granel
    Clinical Rheumatology, 2021, 40 : 4473 - 4483
  • [24] Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance?
    Cavazzana, Ilaria
    Fredi, Micaela
    Franceschini, Franco
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (11)
  • [25] Association between periungual changes and myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies: A retrospective cohort study
    Ueda-Hayakawa, Ikuko
    Maekawa, Aya
    Tonomura, Kyoko
    Kaneda, Emi
    Yamazaki, Yuriko
    Arase, Noriko
    Fujimoto, Manabu
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (03) : 531 - 533
  • [26] Prevalence of myositis specific and associated antibodies in a cohort of patients affected by idiopathic NSIP and no hint of inflammatory myopathies
    Conticini, Edoardo
    d'Alessandro, Miriana
    Cameli, Paolo
    Bergantini, Laura
    Pordon, Elena
    Cassai, Lucia
    Cantarini, Luca
    Bargagli, Elena
    Frediani, Bruno
    Porcelli, Brunetta
    IMMUNOLOGIC RESEARCH, 2023, 71 (05) : 735 - 742
  • [27] Prevalence of myositis specific and associated antibodies in a cohort of patients affected by idiopathic NSIP and no hint of inflammatory myopathies
    Edoardo Conticini
    Miriana d’Alessandro
    Paolo Cameli
    Laura Bergantini
    Elena Pordon
    Lucia Cassai
    Luca Cantarini
    Elena Bargagli
    Bruno Frediani
    Brunetta Porcelli
    Immunologic Research, 2023, 71 : 735 - 742
  • [28] The association between myositis-specific autoantibodies and muscle pathologies in idiopathic inflammatory myopathies
    Xu, Qiu
    Li, Qiu-Xiang
    Bi, Fang-Fang
    Duan, Hui-Qian
    Luo, Yue-Bei
    Yang, Huan
    CLINICAL RHEUMATOLOGY, 2021, 40 (02) : 613 - 624
  • [29] Detection of multiple myositis-specific antibodies: prevalence and clinical significance
    Jerbi, Ameni
    Karoui, Sahar
    Snoussi, Mouna
    Feki, Sawsan
    Damak, Chifa
    Bahloul, Zouheir
    Masmoudi, Hatem
    Marzouk, Sameh
    Hachcicha, Hend
    LABORATORY MEDICINE, 2025,
  • [30] Prognostic value of myositis-specific antibodies in patients with idiopathic interstitial pneumonia
    Wakabayashi, Hiroki
    Iwasaki, Kotaro
    Murakami, Yu
    Takashima, Kenta
    Kaneko, Kaichi
    Matsuzawa, Yasuo
    BMC PULMONARY MEDICINE, 2024, 24 (01):